Ind-Swift Laboratories incorporates wholly owned subsidiary in UAE

20 May 2024 Evaluate

Ind-Swift Laboratories has incorporated wholly owned subsidiary (WOS) in the name and style of ‘ISLL Middle East L.L.C-FZ’ in Dubai, United Arab Emirates (UAE). The certificate of incorporation has been received on May 17, 2024 from the Registrar of Companies of the Meydan - Free Zone.

The WOS intends to strategically invest in pharmaceutical and allied activities. This includes exploring potential acquisitions, tie-ups, or joint ventures. Additionally, the Company aims to establish and operate pharmaceutical manufacturing units.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).


Ind-Swift Lab. Share Price

110.81 9.66 (9.55%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×